Emcure Pharmaceuticals Limited is a leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
The company has been ranked 13th in domestic sales among pharmaceutical companies in India for MAT September 2023 and 4th in market share in its covered markets for the same period. Additionally, it is the leading pharmaceutical company in gynaecology and HIV antiviral therapeutic areas for the MAT September 2023.
In the six months ended September 30, 2023, and the Financial Year 2023, sales in India contributed 50.84% and 53.16% of the company’s total revenue, respectively. The company’s Domestic sales grew at a CAGR of 10.80% between September 2019 and September 2023, outperforming the Indian pharmaceutical market.
As of September 30, 2023, Emcure Pharma employed 552 scientists and operated five research facilities in India. They filed over 1,800 documents globally, including 204 in the EU and 133 in Canada. They had 201 granted patents, 33 pending patent applications, and submitted 102 drug master files.
Emcure Pharmaceuticals has 13 manufacturing facilities in India. These facilities can produce various pharmaceutical and biopharmaceutical products, including pills, liquids, injectables, and complex ingredients such as chiral molecules, iron molecules, and cytotoxic substances.
As of September 30, 2023, the company’s marketing and distribution network in India was supported by over 5,000 field personnel who regularly interacted with healthcare providers. The distribution network included over 5,000 stockists, served by 37 carry-and-forward agents.
Emcure Pharmaceuticals IPO – Details
| IPO Opening Date | 03 July 2024 |
| IPO Closing Date | 05 July 2024 |
| Issue Type | Book Built Issue IPO |
| Issue Size | Total Issue Size: 1,93,65,347 Shares Worth ₹1952.03 Crore Fresh Issue: 79,36,508 Shares Worth ₹800.00 Crore Offer For Sale: 1,14,28,839 Shares Worth ₹1152.03 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹960 – ₹1008 per share |
| Market Lot | 14 Shares |
| Min Order | 14 Shares (1 Lot) |
| Employee Discount | ₹90 |
| Listing At | BSE, NSE |
| Register | Link Intime India Private Ltd |
| QIB Shares Offered | 50% |
| NII (HNI) Shares Offered | 15% |
| Retail Shares Offered | 35% |
Emcure Pharmaceuticals IPO – Date Schedule
| IPO Open Date | 03 July 2024 |
| IPO Close Date | 05 July 2024 |
| Credit of Shares to Demat Account | 08 July 2024 |
| Initiation of Refund | 09 July 2024 |
| Credit of Shares to Demat Account | 09 July 2024 |
| IPO Listing Date | 10 July 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 05, 2024 |
Emcure Pharmaceuticals IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 14 | ₹14,112 |
| Retail (Max) | 14 | 196 | ₹1,97,568 |
| S-HNI (Min) | 15 | 210 | ₹2,11,680 |
| S-HNI (Max) | 70 | 980 | ₹9,87,840 |
| B-HNI (Min) | 71 | 994 | ₹10,01,952 |
Competitive Strengths
- Well-placed to leverage our position in the domestic market.
- Demonstrated capabilities of building brands.
- Large, diversified and fast-growing product portfolio in international markets.
- Strong R&D capabilities driving differentiated portfolio of products.
- Extensive and diversified manufacturing capacity.
- Highly qualified, experienced and entrepreneurial management team and Board.
Company Financials
| Particulars | Total Revenue | Total Expense | Profit After Tax | Total Borrowing |
|---|---|---|---|---|
| 31 March 2022 | 5918.86 | 4946.31 | 702.55 | 2102.19 |
| 31 March 2023 | 6031.71 | 5278.35 | 561.84 | 2202.42 |
| 31 March 2024 | 6715.24 | 5978.08 | 527.57 | 2091.93 |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 16.90% |
| ROCE | 19.37% |
| Debt/Equity | 0.67 |
| RoNW | 16.87% |
| P/BV | 6.18 |
| Pre IPO | Post IPO | |
| EPS (Rs) | 29.17 | 27.95 |
| P/E (x) | 34.55 | 36.07 |
Object Of The Issue
- Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the company; and
- General corporate purposes.
Emcure Pharmaceuticals IPO Peer Comparison
| S. No. | Face Value | Company Name | PE |
| 1 | 10 | Abbott India Limited | 47.43 |
| 2 | 2 | Alkem Laboratories Limited | 33.86 |
| 3 | 1 | J. B. Chemicals & Pharmaceuticals Limited | 50.49 |
| 4 | 2 | Cipla Limited | 30.10 |
| 5 | 5 | Dr. Reddy’s Laboratories Limited | 17.93 |
| 6 | 5 | Torrent Pharmaceuticals Limited | 57.74 |
| 7 | 1 | Mankind Pharma Limited | 45.30 |
Emcure Pharmaceuticals IPO Promoter Holding
| Pre Issue Share Holding | 82.97% |
| Post Issue Share Holding | 77.85% |
Emcure Pharmaceuticals IPO Prospectus
Company Contact Information
| Emcure Pharmaceuticals Limited Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune -411 057 Phone: +91 20 3507 0033 Email: investors@emcure.co.in Website: https://www.emcure.com/ |
Emcure Pharmaceuticals IPO Registrar
| Link Intime India Private Ltd Phone: +91-22-4918 6270 Email: emcure.ipo@linkintime.co.in Website: https://linkintime.co.in/initial_offer/public-issues.html |
Emcure Pharmaceuticals IPO Lead Manager(s)
| 1. Kotak Mahindra Capital Company Limited 2. Axis Capital Limited 3. Jefferies India Private Limited 4. J. P. Morgan India Private Limited |
Emcure Pharmaceuticals IPO FAQs
| What is Emcure Pharmaceuticals IPO? Emcure Pharmaceuticals IPO is a main-board IPO. The issue is priced at ₹960 to ₹1008 per equity share. The IPO is to be listed on BSE & NSE. |
| When Emcure Pharmaceuticals IPO will open? The IPO is to open on 03 July 2024 for QIB, NII, and Retail Investors. |
| What is Emcure Pharmaceuticals IPO Investors Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| How to Apply the Emcure Pharmaceuticals IPO? You can apply Emcure Pharmaceuticals IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form. |
| How to Apply the Emcure Pharmaceuticals IPO through Angle One? Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Emcure Pharmaceuticals”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Angle One. |
| How to Apply the Emcure Pharmaceuticals IPO through 5 Paisa? Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Emcure Pharmaceuticals“. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa. |
| How to Apply the Emcure Pharmaceuticals IPO through Upstox? Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Emcure Pharmaceuticals”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox. |
| How to Apply the Emcure Pharmaceuticals IPO through IIFL? Log in to IIFL Application with your credentials. Select the IPO. You will see the IPO Name “Emcure Pharmaceuticals”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with IIFL. |
| What is Emcure Pharmaceuticals IPO Size? Emcure Pharmaceuticals IPO size is ₹1952.03 Crore. |
| What is Emcure Pharmaceuticals IPO Price Band? Emcure Pharmaceuticals IPO Price Band is ₹960 to ₹1008. |
| What is Emcure Pharmaceuticals IPO Minimum and Maximum Lot Size for retail? The minimum bid is 14 Shares with ₹14,112 amount while the maximum bid is 196 Shares with ₹1,97,568. |
| What is the Emcure Pharmaceuticals IPO Allotment Date? Emcure Pharmaceuticals IPO allotment date is 08 July 2024. |
| What is the Emcure Pharmaceuticals IPO Listing Date? Emcure Pharmaceuticals IPO listing date is 10 July 2024. The IPO is to be listed on BSE and NSE. |
